A detailed history of Pinz Capital Management, LP transactions in Adverum Biotechnologies, Inc. stock. As of the latest transaction made, Pinz Capital Management, LP holds 15,700 shares of ADVM stock, worth $123,716. This represents 0.03% of its overall portfolio holdings.

Number of Shares
15,700
Holding current value
$123,716
% of portfolio
0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

BUY
$0.96 - $9.68 $15,072 - $151,976
15,700 New
15,700 $15,000
Q4 2021

Feb 14, 2022

SELL
$1.74 - $2.4 $93,264 - $128,640
-53,600 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$2.08 - $3.6 $111,488 - $192,960
53,600 New
53,600 $116,000

Others Institutions Holding ADVM

About Adverum Biotechnologies, Inc.


  • Ticker ADVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 99,333,600
  • Market Cap $783M
  • Description
  • Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...
More about ADVM
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.